RAFAEL HOLDINGS INC-CLASS B (RFL) Stock News

USA - NYSE:RFL - US75062E1064 - Common Stock

1.36 USD

0 (0%)

Last: 9/26/2025, 8:04:00 PM

1.35 USD

-0.01 (-0.74%)

After Hours: 9/26/2025, 8:04:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

RFL Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Benzinga - Mentions: ONCO RPID HSDT SRRK ...

12 Health Care Stocks Moving In Monday's After-Market Session

11 days ago - By: Rafael Holdings, Inc.

Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old

11 days ago - By: Rafael Holdings, Inc. - Mentions: NYSE

Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old

a month ago - By: Rafael Holdings, Inc.

Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)

a month ago - By: Rafael Holdings, Inc. - Mentions: NYSE

Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)

2 months ago - By: Benzinga - Mentions: CYCC CRL ONMD HCTI ...

12 Health Care Stocks Moving In Monday's After-Market Session

3 months ago - By: Rafael Holdings, Inc.

Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data

3 months ago - By: Rafael Holdings, Inc. - Mentions: NYSE

Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data

4 months ago - By: Rafael Holdings, Inc.

Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

4 months ago - By: Rafael Holdings, Inc. - Mentions: NYSE

Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

4 months ago - By: Rafael Holdings, Inc.

Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering

4 months ago - By: Rafael Holdings, Inc. - Mentions: NYSE

Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering

4 months ago - By: Rafael Holdings, Inc.

Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of

4 months ago - By: Rafael Holdings, Inc. - Mentions: NYSE

Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of

5 months ago - By: Rafael Holdings, Inc.

Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

5 months ago - By: Rafael Holdings, Inc.

Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

5 months ago - By: Rafael Holdings, Inc.

Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

5 months ago - By: Rafael Holdings, Inc.

Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role

5 months ago - By: Rafael Holdings, Inc.

Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role

6 months ago - By: Rafael Holdings, Inc.

Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals

6 months ago - By: Rafael Holdings, Inc. - Mentions: CYTH

Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals

7 months ago - By: Rafael Holdings, Inc. - Mentions: CYTH

Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results

7 months ago - By: Rafael Holdings, Inc.

Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results

10 months ago - By: Rafael Holdings, Inc.

Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

10 months ago - By: Rafael Holdings, Inc. - Mentions: CYTH

Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

a year ago - By: Rafael Holdings, Inc.

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

a year ago - By: Rafael Holdings, Inc. - Mentions: CYTH

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

a year ago - By: Halper Sadeh LLC - Mentions: CDE SMC COFS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, SMC, COFS, RFL on Behalf of Shareholders